What is it about?
We looked at the medications used by a group of research participants in the Parkinson's Progression Markers Initiative study to see what medications were for different non-motor symptoms and how often the drugs appeared in medication records.
Featured Image
Photo by Laurynas Mereckas on Unsplash
Why is it important?
There are only a few drugs specifically approved for Parkinson's disease non-motor symptoms. We were interested in characterizing what people were taking to gain a better understanding.
Perspectives
Many assessments used for non-motor symptom prevalence or severity do not take medication use into consideration, and, in general, medication data are notoriously difficult to work with. I hope we can re-evaluate how we collect, analyze, and utilize medication data from clinical studies.
Monica Javidnia
University of Rochester
Read the Original
This page is a summary of: Pharmacotherapy Use for Non-Motor Symptoms Among de novo Parkinson’s Disease Parkinson’s Progression Markers Initiative Participants, Journal of Parkinson’s Disease, May 2020, IOS Press,
DOI: 10.3233/jpd-201973.
You can read the full text:
Resources
Contributors
The following have contributed to this page
